| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 101,501 | 93,553 | 79,609 | 84,202 | | Cost of Revenue | 28,678 | 27,065 | 16,381 | (14,835) | | | Gross Profit | 72,823 | 66,488 | 63,228 | 99,037 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 41,968 | 33,587 | 43,464 | 76,815 | | Non Recurring | 15 |
-
| (15) | 6,525 | | Others | 8,400 | 8,387 | 8,361 | 8,077 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 22,455 | 24,514 | 11,418 | 7,620 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 226 | 378 | 172 | 388 | | Earnings Before Interest And Taxes | 22,666 | 24,892 | 11,590 | 8,008 | | Interest Expense | 5,861 | 5,659 | 5,294 | 5,230 | | Income Before Tax | 16,805 | 19,233 | 6,296 | 2,778 | | Income Tax Expense | 7,107 | 7,734 | 1,364 | (88) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,698 | 11,499 | 4,932 | 2,866 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,698 | 11,499 | 4,932 | 2,866 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,698 | $11,499 | $4,932 | $2,866 |
|
0.13% Nasdaq 
Income Statement
